DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,400 | -62.2% | 40,000 | +60.0% | 0.01% | -60.0% |
| Q2 2023 | $96,250 | +27.5% | 25,000 | 0.0% | 0.02% | +25.0% |
| Q1 2023 | $75,500 | +47.3% | 25,000 | 0.0% | 0.01% | +33.3% |
| Q4 2022 | $51,250 | -99.9% | 25,000 | 0.0% | 0.01% | -43.8% |
| Q3 2022 | $86,500,000 | -17.8% | 25,000 | 0.0% | 0.02% | -11.1% |
| Q2 2022 | $105,250,000 | -15.6% | 25,000 | -39.1% | 0.02% | -5.3% |
| Q1 2022 | $124,716,000 | -34.6% | 41,025 | 0.0% | 0.02% | -32.1% |
| Q4 2021 | $190,766,000 | -39.7% | 41,025 | 0.0% | 0.03% | -45.1% |
| Q3 2021 | $316,302,000 | +106.6% | 41,025 | +130.5% | 0.05% | +96.2% |
| Q2 2021 | $153,062,000 | – | 17,798 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |